Observed Signal · Aug 13, 2026 · Market Research · Source: persoenlich.com News · Impact: 2/5 · Sentiment: Neutral
Roche and Ypsomed Stay Top in Swiss Reputation Ranking
Swissreputation Group and Pressrelations Schweiz analyzed nearly 90,000 reputation-relevant statements from about 4,000 Swiss online and print sources using an AI-supported method to evaluate media reputation for 40 pharma and medtech companies. The study measured presence (coverage and reach) and tonality (positive/negative reporting) and calculated a Reputation Score (0–100) for each company across six reputation dimensions. In Pharma & Biopharma, Roche ranks first (ahead of MSD, Novartis, Sandoz and AstraZeneca). In MedTech & Diagnostics, Ypsomed remains first (ahead of Medacta, Straumann Group, Alcon and Sonova). The study notes products/services, innovation and economic performance tended to improve media reputation, while workplace issues (layoffs, relocations) and ESG/legal problems harmed reputation. The article was published on 2026-08-13.
Relevant to PR, corporate communications and brand measurement practices; uses AI to quantify media reputation but has limited direct impact on core AdTech infrastructure or major platform policy.
Track Roche Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Swissreputation Group and Pressrelations Schweiz analyzed nearly 90,000 reputation-relevant statements from about 4,000 Swiss online and print sources using an AI-supported method.
- The study measured presence and tonality for 40 pharma and medtech companies and computed a Reputation Score between 0 and 100 across six reputation dimensions.
- In the Pharma & Biopharma category, Roche ranked first, followed by MSD, Novartis, Sandoz and AstraZeneca.
- In the MedTech & Diagnostics category, Ypsomed ranked first, followed by Medacta, Straumann Group, Alcon and Sonova.
- The study found products/services, innovation and economic performance tended to boost media reputation, while workplace issues and ESG/legal problems negatively affected reputation.
Connected Companies & Entities
8 Entities mapped“In the Pharma and Biopharma category, Roche leads the reputation ranking as in the previous year, ahead of MSD, Novartis, Sandoz and AstraZe...”
“The article notes that Novo Nordisk and the Lonza Group fell out of the Top 5 in Pharma compared with the prior ranking.”
“In MedTech and Diagnostics, Ypsomed defends first place ahead of Medacta, the Straumann Group, Alcon and Sonova.”
“The article states that previous leaders Merck, MSD and Lilly were displaced from the top positions but remain in the sample.”
“The article states that previous leaders Merck, MSD and Lilly were displaced from the top positions but remain in the sample.”
“The most positive media images were achieved by Kuros Biosciences, Basilea, Galderma, Santhera and Sandoz.”
“Compared with the first edition, seven pharma companies were added while AbbVie was dropped from the sample.”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
La Roche-Posay Tops YouGov Quality Champions 2026
La Roche-Posay ranked first for the first time in YouGov and the SZ Institut’s 2026 “Quality Champions” ranking, based on more than 950,000 online interviews collected between July 1, 2025 and June 30, 2026. The pharmacy-cosmetics brand of the L’Oréal Group achieved a quality score of 91.6. Manufactum placed second (90.4); Breuninger, Globetrotter and Andechser Natur tied for third (89.6). The Top 10 spans multiple sectors — retail, FMCG, outdoor, travel, fashion and automotive — highlighting broad cross-sector consumer recognition of quality. YouGov’s BrandIndex methodology used existing customers’ assessments to compute a quality score ranging from -100 to +100; only brands with sufficient customer bases and continuous measurement were considered.
EnergieUri Overtakes BKW and Axpo in Media Reputation
A 2026 media-reputation study by swissreputation.group with Pressrelations Schweiz ranks EnergieUri first among 30 Swiss energy companies for coverage during April 2025–March 2026. EnergieUri's top position was driven by an above-average positive tone in reporting linked to projects such as a large battery storage, an alpine solar installation and high-altitude wind turbines, which compensated for lower overall media presence. Longtime leaders BKW and Axpo slipped after increased critical coverage relating to management wages, ESG issues, plant/reactor outages and other controversies. The study used AI-assisted analysis of Swiss media sources and reported that 38% of coverage focused on product/service topics while 20% covered economic results (the latter showing the weakest tone). The study publisher is swissreputation.group; Pressrelations Schweiz contributed media data analysis. Published 2026-05-11.
Most Trusted Brands: Top Stable, Midfield Shifts
Reader's Digest, together with Institut Dialego, published the 2026 "Most Trusted Brands" survey in Switzerland based on 2,300 unprompted responses across 15 product categories. Fielmann received the most mentions overall (747) and again topped the optician/eyewear category. Twelve category leaders remained unchanged from 2025, while the full Top‑3 order changed in two-thirds of categories compared with the prior year. New category leaders include Vicks (cold medicines), Wallis (Swiss holiday regions) and Karma (Coop) for vegan/vegetarian products. Trust in brands that use artificial intelligence rose to 31% (from 24% the previous year). The study recorded 2,140 distinct brand terms; the publisher did not provide sampling details or margins of error. Andreas Karl (Managing Director, Reader's Digest D/A/CH) commented on brands' obligation to provide clear orientation.
Receive all future signals for Roche & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.